Europe Pneumococcal Vaccine Market Size study, by Vaccine Type (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine) by Product (Prevnar 13, Synflorix, Pneumovax 23, Vaxneuvance, Pneumosil, Other Products) by End-use (Public Sector, Private Sector) and Country Forecasts 2022-2032
Europe Pneumococcal Vaccine Market is valued approximately USD 1.23 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.84% over the forecast period 2024-2032. The Pneumococcal Vaccine is a vaccine that prevents against infection with Streptococcus pneumoniae bacteria, also known as pneumococcus. This bacterium can cause pneumonia, meningitis, and bacteremia. The vaccination works by stimulating the immune system to produce antibodies against certain bacterial strains, preventing infection. Also, continuous advancements in vaccine technology have led to the development of improved pneumococcal vaccines with enhanced efficacy and safety profiles. This has further stimulated market growth as healthcare providers and patients opt for newer and more effective vaccines. Thus, this trend is anticipated to support the growth of Europe Pneumococcal Vaccine Market.
Moreover, growing awareness among healthcare professionals and the general public about the importance of pneumococcal vaccination in preventing pneumonia and other pneumococcal diseases drives the demand for vaccines. Also, government initiatives and vaccination programs aimed at preventing pneumococcal diseases among infants, children, and older adults contribute significantly to market growth. These initiatives often include free or subsidized vaccination programs, increasing accessibility and affordability. Additionally, the increasing incidence of pneumococcal diseases, such as pneumonia, meningitis, and septicemia, particularly among vulnerable populations such as infants, elderly individuals, and those with weakened immune systems, fuels the demand for pneumococcal vaccines. However, the stringent regulatory processes and approval requirements are expected to hinder the Europe Pneumococcal Vaccine market growth during the forecast period 2024-2032.
The key countries considered for the Europe Pneumococcal Vaccine market study includes UK, Germany, France, Italy, Spain, and Rest of Europe. In 2023, Germany was the largest market in terms of revenue. the rising incidences of pneumococcal diseases, such as pneumonia, meningitis, and sepsis, have propelled the demand for pneumococcal vaccines. With a growing elderly population and individuals with chronic diseases who are more susceptible to pneumococcal infections, there's a heightened awareness regarding preventive measures such as vaccination. Whereas, the United Kingdom is expected to grow with the highest CAGR during the forecast period 2024-2032.
Major market player included in this report are:
GSK plc
Sanofi SE
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
The detailed segments and sub-segment of the market are explained below:
By Vaccine Type
Pneumococcal Conjugate Vaccine
Pneumococcal Polysaccharide Vaccine
By Product
Prevnar 13
Synflorix
Pneumovax 23
Vaxneuvance
Pneumosil
Other Products
By End-use
Public Sector
Private Sector
By Region:
Europe
UK
Germany
France
Spain
Italy
ROE
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market
Moreover, growing awareness among healthcare professionals and the general public about the importance of pneumococcal vaccination in preventing pneumonia and other pneumococcal diseases drives the demand for vaccines. Also, government initiatives and vaccination programs aimed at preventing pneumococcal diseases among infants, children, and older adults contribute significantly to market growth. These initiatives often include free or subsidized vaccination programs, increasing accessibility and affordability. Additionally, the increasing incidence of pneumococcal diseases, such as pneumonia, meningitis, and septicemia, particularly among vulnerable populations such as infants, elderly individuals, and those with weakened immune systems, fuels the demand for pneumococcal vaccines. However, the stringent regulatory processes and approval requirements are expected to hinder the Europe Pneumococcal Vaccine market growth during the forecast period 2024-2032.
The key countries considered for the Europe Pneumococcal Vaccine market study includes UK, Germany, France, Italy, Spain, and Rest of Europe. In 2023, Germany was the largest market in terms of revenue. the rising incidences of pneumococcal diseases, such as pneumonia, meningitis, and sepsis, have propelled the demand for pneumococcal vaccines. With a growing elderly population and individuals with chronic diseases who are more susceptible to pneumococcal infections, there's a heightened awareness regarding preventive measures such as vaccination. Whereas, the United Kingdom is expected to grow with the highest CAGR during the forecast period 2024-2032.
Major market player included in this report are:
GSK plc
Sanofi SE
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
The detailed segments and sub-segment of the market are explained below:
By Vaccine Type
Pneumococcal Conjugate Vaccine
Pneumococcal Polysaccharide Vaccine
By Product
Prevnar 13
Synflorix
Pneumovax 23
Vaxneuvance
Pneumosil
Other Products
By End-use
Public Sector
Private Sector
By Region:
Europe
UK
Germany
France
Spain
Italy
ROE
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market
CHAPTER 1. EUROPE PNEUMOCOCCAL VACCINE MARKET DEFINITION AND RESEARCH ASSUMPTIONS
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Europe Pneumococcal Vaccine Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Vaccine Type
2.3.2. By Product
2.3.3. By End-use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
CHAPTER 3. EUROPE PNEUMOCOCCAL VACCINE MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. EUROPE PNEUMOCOCCAL VACCINE MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. EUROPE PNEUMOCOCCAL VACCINE MARKET SIZE & FORECASTS BY VACCINE TYPE 2022-2032
5.1. Pneumococcal Conjugate Vaccine
5.2. Pneumococcal Polysaccharide Vaccine
CHAPTER 6. EUROPE PNEUMOCOCCAL VACCINE MARKET SIZE & FORECASTS BY PRODUCT 2022-2032
6.1. Prevnar
6.2. Synflorix
6.3. Pneumovax
6.4. Vaxneuvance
6.5. Pneumosil
6.6. Other Products
CHAPTER 7. EUROPE PNEUMOCOCCAL VACCINE MARKET SIZE & FORECASTS BY END-USE 2022-2032
7.1. Public Sector
7.2. Private Sector
CHAPTER 8. EUROPE PNEUMOCOCCAL VACCINE MARKET SIZE & FORECASTS BY COUNTRY 2022-2032
8.1. U.K. Pneumococcal Vaccine Market
8.1.1. Vaccine Type breakdown size & forecasts, 2022-2032
8.1.2. Product breakdown size & forecasts, 2022-2032
8.1.3. End-use breakdown size & forecasts, 2022-2032
8.2. Germany Pneumococcal Vaccine Market
8.3. France Pneumococcal Vaccine Market
8.4. Spain Pneumococcal Vaccine Market
8.5. Italy Pneumococcal Vaccine Market
8.6. Rest of Europe Pneumococcal Vaccine Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. GSK plc
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Sanofi SE
9.3.3. Company
9.3.4. Company
9.3.5. Company
9.3.6. Company
9.3.7. Company
9.3.8. Company
9.3.9. Company
9.3.10. Company
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Europe Pneumococcal Vaccine Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Vaccine Type
2.3.2. By Product
2.3.3. By End-use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
CHAPTER 3. EUROPE PNEUMOCOCCAL VACCINE MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. EUROPE PNEUMOCOCCAL VACCINE MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. EUROPE PNEUMOCOCCAL VACCINE MARKET SIZE & FORECASTS BY VACCINE TYPE 2022-2032
5.1. Pneumococcal Conjugate Vaccine
5.2. Pneumococcal Polysaccharide Vaccine
CHAPTER 6. EUROPE PNEUMOCOCCAL VACCINE MARKET SIZE & FORECASTS BY PRODUCT 2022-2032
6.1. Prevnar
6.2. Synflorix
6.3. Pneumovax
6.4. Vaxneuvance
6.5. Pneumosil
6.6. Other Products
CHAPTER 7. EUROPE PNEUMOCOCCAL VACCINE MARKET SIZE & FORECASTS BY END-USE 2022-2032
7.1. Public Sector
7.2. Private Sector
CHAPTER 8. EUROPE PNEUMOCOCCAL VACCINE MARKET SIZE & FORECASTS BY COUNTRY 2022-2032
8.1. U.K. Pneumococcal Vaccine Market
8.1.1. Vaccine Type breakdown size & forecasts, 2022-2032
8.1.2. Product breakdown size & forecasts, 2022-2032
8.1.3. End-use breakdown size & forecasts, 2022-2032
8.2. Germany Pneumococcal Vaccine Market
8.3. France Pneumococcal Vaccine Market
8.4. Spain Pneumococcal Vaccine Market
8.5. Italy Pneumococcal Vaccine Market
8.6. Rest of Europe Pneumococcal Vaccine Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. GSK plc
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Sanofi SE
9.3.3. Company
9.3.4. Company
9.3.5. Company
9.3.6. Company
9.3.7. Company
9.3.8. Company
9.3.9. Company
9.3.10. Company
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
LIST OF TABLES
TABLE 1. Europe Pneumococcal Vaccine market, report scope
TABLE 2. Europe Pneumococcal Vaccine market estimates & forecasts by Country 2022-2032 (USD Billion)
TABLE 3. Europe Pneumococcal Vaccine market estimates & forecasts by Vaccine Type 2022-2032 (USD Billion)
TABLE 4. Europe Pneumococcal Vaccine market estimates & forecasts by Product 2022-2032 (USD Billion)
TABLE 5. Europe Pneumococcal Vaccine market estimates & forecasts by End-use 2022-2032 (USD Billion)
TABLE 6. Europe Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Europe Pneumococcal Vaccine market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Europe Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Europe Pneumococcal Vaccine market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Europe Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Europe Pneumococcal Vaccine market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Europe Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Europe Pneumococcal Vaccine market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Europe Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion) Europe Pneumococcal Vaccine market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. UK Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. UK Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. UK Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Germany Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Germany Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Germany Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 21. France Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 22. France Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 23. France Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 24. Italy Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 25. Italy Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 26. Italy Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 27. Spain Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 28. Spain Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 29. Spain Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 30. RoE Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 31. RoE Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 32. RoE Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 33. List of secondary sources, used in the study of Europe Pneumococcal Vaccine Market.
TABLE 34. List of primary sources, used in the study of Europe Pneumococcal Vaccine Market.
TABLE 35. Years considered for the study.
TABLE 36. Exchange rates considered
TABLE 1. Europe Pneumococcal Vaccine market, report scope
TABLE 2. Europe Pneumococcal Vaccine market estimates & forecasts by Country 2022-2032 (USD Billion)
TABLE 3. Europe Pneumococcal Vaccine market estimates & forecasts by Vaccine Type 2022-2032 (USD Billion)
TABLE 4. Europe Pneumococcal Vaccine market estimates & forecasts by Product 2022-2032 (USD Billion)
TABLE 5. Europe Pneumococcal Vaccine market estimates & forecasts by End-use 2022-2032 (USD Billion)
TABLE 6. Europe Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Europe Pneumococcal Vaccine market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Europe Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Europe Pneumococcal Vaccine market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Europe Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Europe Pneumococcal Vaccine market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Europe Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Europe Pneumococcal Vaccine market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Europe Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion) Europe Pneumococcal Vaccine market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. UK Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. UK Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. UK Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Germany Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Germany Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Germany Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 21. France Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 22. France Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 23. France Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 24. Italy Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 25. Italy Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 26. Italy Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 27. Spain Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 28. Spain Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 29. Spain Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 30. RoE Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 31. RoE Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 32. RoE Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 33. List of secondary sources, used in the study of Europe Pneumococcal Vaccine Market.
TABLE 34. List of primary sources, used in the study of Europe Pneumococcal Vaccine Market.
TABLE 35. Years considered for the study.
TABLE 36. Exchange rates considered
LIST OF FIGURES
FIG 1. Europe Pneumococcal Vaccine market, research methodology
FIG 2. Europe Pneumococcal Vaccine market, market estimation techniques
FIG 3. Europe market size estimates & forecast methods.
FIG 4. Europe Pneumococcal Vaccine market, key trends 2023
FIG 5. Europe Pneumococcal Vaccine market, growth prospects 2022-2032
FIG 6. Europe Pneumococcal Vaccine market, porters 5 force model
FIG 7. Europe Pneumococcal Vaccine market, pestel analysis
FIG 8. Europe Pneumococcal Vaccine market, value chain analysis
FIG 9. Europe Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 10. Europe Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 11. Europe Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 12. Europe Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 13. Europe Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 14. Europe Pneumococcal Vaccine market, Country snapshot 2022 & 2032
FIG 15. Europe Pneumococcal Vaccine market 2022 & 2032 (USD Billion)
FIG 16. Europe Pneumococcal Vaccine market, company market share analysis (2023)
FIG 1. Europe Pneumococcal Vaccine market, research methodology
FIG 2. Europe Pneumococcal Vaccine market, market estimation techniques
FIG 3. Europe market size estimates & forecast methods.
FIG 4. Europe Pneumococcal Vaccine market, key trends 2023
FIG 5. Europe Pneumococcal Vaccine market, growth prospects 2022-2032
FIG 6. Europe Pneumococcal Vaccine market, porters 5 force model
FIG 7. Europe Pneumococcal Vaccine market, pestel analysis
FIG 8. Europe Pneumococcal Vaccine market, value chain analysis
FIG 9. Europe Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 10. Europe Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 11. Europe Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 12. Europe Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 13. Europe Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 14. Europe Pneumococcal Vaccine market, Country snapshot 2022 & 2032
FIG 15. Europe Pneumococcal Vaccine market 2022 & 2032 (USD Billion)
FIG 16. Europe Pneumococcal Vaccine market, company market share analysis (2023)
